Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion

Colorectal cancer (CRC) is a public health problem: it is the third most common cancer in men (746,000 new cases/year) and the second in women (614,000 new cases/year), representing the second leading cause of death by cancer worldwide. The survival of patients with metastatic CRC (mCRC) has increas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical colorectal cancer 2020-09, Vol.19 (3), p.165-177
Hauptverfasser:	Fernández-Montes, Ana, Grávalos, Cristina, Pericay, Carles, Safont, Ma José, Benavides, Manuel, Élez, Elena, García-Alfonso, Pilar, García-Paredes, Beatriz, Carrato, Alfredo, Aranda, Enrique
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - standards Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Biomarkers, Tumor - genetics Clinical Decision-Making - methods Clinical Trials as Topic Colorectal neoplasms Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Drug Resistance, Neoplasm Humans Microsatellite Instability Mutations Patient Selection Practice Guidelines as Topic Progression-Free Survival Refractory Spain - epidemiology Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!